The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Much Is The Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?
The market for ophthalmic artificial intelligence-assisted diagnosis has observed significant growth in recent years. This sector is anticipated to expand from $2.17 billion in 2025 to $2.57 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 18.5%. The expansion witnessed in previous periods can be attributed to the rising adoption of digital imaging devices, an increase in the prevalence of eye diseases, improved awareness of early diagnosis, the integration of AI in clinical trials, and advancements in retinal imaging technology.
The ophthalmic artificial intelligence-assisted diagnosis market size is anticipated to expand significantly over the coming years. This market is set to reach $5.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 18.2%. This growth during the forecast period is propelled by factors such as the increasing development of cloud-based AI diagnostic platforms, the wider availability of tele-ophthalmology services, enhanced AI algorithms for uncommon eye disorders, strategic alliances between AI innovators and hospitals, and the growing acceptance of predictive ophthalmology. Notable trends for the forecast period encompass AI-driven retinal imaging analysis, deep learning-supported disease detection, predictive ophthalmology models, automated patient record examination, and the integration of AI within clinical operational procedures.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28285&type=smp
What Drivers Are Influencing The Ophthalmic Artificial Intelligence-Assisted Diagnosis Market?
The increasing occurrence of eye conditions is anticipated to drive the expansion of the ophthalmic artificial intelligence-assisted diagnosis market in the future. Eye disorders are defined as health issues or irregularities impacting the eye’s structure or function, which can potentially diminish vision or ocular well-being. The surge in eye disorders is attributed to increased screen usage from digital devices, leading to digital eye strain, dryness, and lasting vision problems resulting from extended blue light exposure and decreased blinking. Ophthalmic artificial intelligence-assisted diagnosis provides assistance by examining medical imagery and patient records to identify, categorize, and foresee eye conditions both early and precisely, thereby facilitating prompt treatment and mitigating the chance of vision impairment. As an example, the World Health Organization (WHO), a United Nations agency based in Switzerland, reported in August 2023 that 2023 estimates reveal over 2.2 billion individuals suffer from near or distance vision impairment. Of these, more than 1 billion cases are either preventable or have not been treated. Refractive errors and cataracts continue to be the primary causes, yet only 36% of those with refractive error-related impairment and a mere 17% of individuals with cataract-related impairment have access to effective interventions. Consequently, the increasing prevalence of eye disorders is a significant factor propelling the expansion of the ophthalmic artificial intelligence-assisted diagnosis market.
What Major Segment Divisions Exist Within The Ophthalmic Artificial Intelligence-Assisted Diagnosis Market?
The ophthalmic artificial intelligence-assisted diagnosis market covered in this report is segmented –
1) By Type: Cloud-Based, On-Premises
2) By Technology: Deep Learning, Machine Learning, Computer Vision, Other Technologies
3) By Application: Hospital, Clinic, Imaging Centre
Subsegments:
1) By Cloud-Based: Public Cloud, Private Cloud, Hybrid Cloud
2) By On-Premises: Local Server Deployment, Enterprise Data Center Deployment, Private Network Deployment
How Are Trends Shaping The Direction Of The Ophthalmic Artificial Intelligence-Assisted Diagnosis Market?
Leading companies in the ophthalmic artificial intelligence-assisted diagnosis market are concentrating on developing innovative solutions, such as an ocular data-as-a-service platform, to boost diagnostic accuracy, streamline patient care, and enable predictive insights for various eye disorders. An ocular data-as-a-service platform is defined as a digital solution that provides on-demand eye health data, allowing ophthalmologists, clinics, and AI diagnostic tools to access, share, and analyze retinal images and other ocular information remotely for enhanced diagnosis, monitoring, and research. For example, in May 2025, Topcon Healthcare Solutions Inc., a US-based digital healthcare solutions company, unveiled IDHea, which is designed to streamline ophthalmic diagnostics and improve patient outcomes. This cloud-based platform accelerates AI and digital health innovation by offering quick, secure access to real-world and clinical ocular datasets. It empowers researchers to achieve breakthroughs in both eye and systemic disease care by converting clinical data into actionable, AI-powered insights. Built on the FAST principle—Fast, Accessible, Safe, and Transparent—IDHea supports predictive, personalized, and proactive patient care while adhering to stringent privacy and governance standards.
Which Companies Are Leading Innovation In The Ophthalmic Artificial Intelligence-Assisted Diagnosis Market?
Major companies operating in the ophthalmic artificial intelligence-assisted diagnosis market are IDx Technologies Inc., Digital Diagnostics Inc., AEYE Health Inc., Eyenuk Inc., OphtAI, Oivi Tech Private Limited, Altris Inc., JuneBrain Inc., Mediwhale Inc., MONA.health BV, Remidio Innovative Solutions Pvt. Ltd., Retinalyze System A/S, Retmarker, RetinaRisk, Ikerian AG, VoxelCloud Inc., Visulytix Ltd., Aiforia Technologies Plc, DeepTek Inc., EyRIS Pte Ltd., Neurodynamics Solutions Inc.
Read the full ophthalmic artificial intelligence-assisted diagnosis market report here:
Which Regions Are Expected To Experience Rapid Expansion In The Ophthalmic Artificial Intelligence-Assisted Diagnosis Market?
North America was the largest region in the ophthalmic artificial intelligence-assisted diagnosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ophthalmic artificial intelligence-assisted diagnosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=28285&type=smp
Browse Through More Reports Similar to the Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market 2026, By The Business Research Company
Ophthalmic Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/ophthalmic-devices-global-market-report
Ophthalmic Workstations Market Report 2026
https://www.thebusinessresearchcompany.com/report/ophthalmic-workstations-global-market-report
Artificial Intelligence In The Diagnostic Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model